Global Diabetic Retinopathy Pipeline Report 2016 – Review of 41 Therapeutics Companies & Drug Profile Activity – Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Diabetic Retinopathy - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Diabetic Retinopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases.

Full Story →